BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Ariad Pharmaceuticals, Inc. 

26 Landsdowne Street

Cambridge  Massachusetts  02139  U.S.A.
Phone: 617-494-0400 Fax: 617-494-8144


SEARCH JOBS

View Clinical Trials from BioPharm Insight


ARIAD Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts and Lausanne, Switzerland, is an integrated global oncology company focused on transforming the lives of cancer patients with breakthrough medicines. ARIAD is working on new medicines to advance the treatment of various forms of chronic and acute leukemia, lung cancer and other difficult-to-treat cancers. ARIAD utilizes computational and structural approaches to design small-molecule drugs that overcome resistance to existing cancer medicines. For additional information, visit http://www.ariad.com or follow ARIAD on Twitter (@ARIADPharm).


 Key Statistics


Email:
Ownership: Public

Web Site: Ariad
Employees:
Symbol: ARIA
 









 Company News
Ariad (ARIA) To Present At The Cowen and Company 35th Annual Health Care Conference 2/24/2015 11:05:29 AM
Ariad (ARIA) Confirms Receipt Of Sarissa Capital Management’s Nomination Of Director Candidates 2/20/2015 12:59:02 PM
Ariad (ARIA) Touts Impressive Financials But Investors Still Push for CEO Ouster 2/20/2015 6:38:59 AM
Ariad Pharmaceuticals (ARIA) Reports 2014 Financial Results, Provides 2015 Financial Guidance And Outlines Strategic Objectives 2/19/2015 12:25:11 PM
Activist Fund Wants to Oust Ariad Pharmaceuticals (ARIA) CEO Harvey Berger 2/13/2015 7:36:20 AM
Ariad Pharmaceuticals, Inc. (ARIA) To Present At The RBC Capital Markets’ Healthcare Conference 2/11/2015 12:47:18 PM
Ariad Pharmaceuticals, Inc. (ARIA) To Present At The Leerink Global Healthcare Conference 2/3/2015 12:16:27 PM
Ariad Pharmaceuticals, Inc. (ARIA) To Webcast Conference Call On Fourth Quarter And Year-End 2014 Financial Results 1/29/2015 11:15:43 AM
AstraZeneca PLC (AZN) Rumored to be Stalking Massachusetts's Ariad Pharmaceuticals, Inc. (ARIA) 1/28/2015 12:04:43 PM
Ariad Pharmaceuticals, Inc. (ARIA) Announces Appointment Of Thomas J. DesRosier, Senior Pharmaceutical-Industry Counsel, As Chief Legal And Administrative Officer 1/22/2015 11:03:18 AM
12345678910...